Neuman MG - Search Results

1

Monitoring adverse drug reactions to sulfonamide antibiotics in human immunodeficiency virus-infected individuals.

Neuman MG, Malkiewicz IM, Phillips EJ, Rachlis AR, Ong D, Yeung E, Shear NH. Neuman MG, et al. Ther Drug Monit. 2002 Dec;24(6):728-36. doi: 10.1097/00007691-200212000-00008. Ther Drug Monit. 2002. PMID: 12451289

2

Safety of celecoxib in individuals allergic to sulfonamide: a pilot study.

Shapiro LE, Knowles SR, Weber E, Neuman MG, Shear NH. Shapiro LE, et al. Among authors: neuman mg. Drug Saf. 2003;26(3):187-95. doi: 10.2165/00002018-200326030-00004. Drug Saf. 2003. PMID: 12580647 Clinical Trial.

3

A novel lymphocyte toxicity assay to assess drug hypersensitivity syndromes.

Neuman MG, Malkiewicz IM, Shear NH. Neuman MG, et al. Clin Biochem. 2000 Oct;33(7):517-24. doi: 10.1016/s0009-9120(00)00146-6. Clin Biochem. 2000. PMID: 11124336

4

Mechanism of Impila (Callilepis laureola)-induced cytotoxicity in Hep G2 cells.

Popat A, Shear NH, Malkiewicz I, Thomson S, Neuman MG. Popat A, et al. Among authors: neuman mg. Clin Biochem. 2002 Feb;35(1):57-64. doi: 10.1016/s0009-9120(02)00271-0. Clin Biochem. 2002. PMID: 11937079

5

Immunopathogenesis of hypersensitivity syndrome reactions to sulfonamides.

Neuman MG, Shear NH, Malkiewicz IM, Taeri M, Shapiro LE, Krivoy N, Haber J, Gomez M, Fish J, Cartotto R, Cohen L. Neuman MG, et al. Transl Res. 2007 May;149(5):243-53. doi: 10.1016/j.trsl.2006.12.001. Transl Res. 2007. PMID: 17466923

6

Predicting possible zonisamide hypersensitivity syndrome.

Neuman MG, Shear NH, Malkiewicz IM, Kessas M, Lee AW, Cohen L. Neuman MG, et al. Exp Dermatol. 2008 Dec;17(12):1045-51. doi: 10.1111/j.1600-0625.2008.00748.x. Epub 2008 Jul 7. Exp Dermatol. 2008. PMID: 18637135

7

Drug-induced severe adverse reaction enhanced by human herpes virus-6 reactivation.

Neuman MG, McKinney KK, Nanau RM, Kong V, Malkiewicz I, Mazulli T, Moussa G, Cohen LB. Neuman MG, et al. Transl Res. 2013 May;161(5):430-40. doi: 10.1016/j.trsl.2012.12.012. Epub 2013 Jan 16. Transl Res. 2013. PMID: 23333110

8

Kinetics of serum cytokines reflect changes in the severity of chronic hepatitis C presenting minimal fibrosis.

Neuman MG, Benhamou JP, Malkiewicz IM, Ibrahim A, Valla DC, Martinot-Peignoux M, Asselah T, Bourliere M, Katz GG, Shear NH, Marcellin P. Neuman MG, et al. J Viral Hepat. 2002 Mar;9(2):134-40. doi: 10.1046/j.1365-2893.2002.00343.x. J Viral Hepat. 2002. PMID: 11876796

9

Serum tumour necrosis factor-alpha and transforming growth factor-beta levels in chronic hepatitis C patients are immunomodulated by therapy.

Neuman MG, Benhamou JP, Bourliere M, Ibrahim A, Malkiewicz I, Asselah T, Martinot-Peignoux M, Shear NH, Katz GG, Akremi R, Benali S, Boyer N, Lecomte L, Le Breton V, Le Guludec G, Marcellin P. Neuman MG, et al. Cytokine. 2002 Jan 21;17(2):108-17. doi: 10.1006/cyto.2001.0997. Cytokine. 2002. PMID: 11886178 Clinical Trial.

10

Ethanol signals for apoptosis in cultured skin cells.

Neuman MG, Haber JA, Malkiewicz IM, Cameron RG, Katz GG, Shear NH. Neuman MG, et al. Alcohol. 2002 Apr;26(3):179-90. doi: 10.1016/s0741-8329(02)00198-2. Alcohol. 2002. PMID: 12057780

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

167 results

Search Page

Filters